Shandong Sinobioway Biomedicine Co Ltd Net Asset Quality Index
Shandong Sinobioway Biomedicine Co Ltd net asset quality index. Shandong Sinobioway Biomedicine Co Ltd (002581) has a Net Asset Quality Index of 91.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.05 Billion minus total liabilities of CN¥176.06 Million yields net assets of CN¥1.87 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Shandong Sinobioway Biomedicine Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
Net asset quality index of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. This chart shows how Shandong Sinobioway Biomedicine Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 91.4%, representing net assets of CN¥1.87 Billion against total assets of CN¥2.05 Billion CNY. Check 002581 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Shandong Sinobioway Biomedicine Co Ltd Net Asset Quality Index by Year (2007–2025)
Shandong Sinobioway Biomedicine Co Ltd net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002581 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.8% | CN¥1.95 Billion | CN¥2.17 Billion | CN¥222.00 Million | ▼ -2.3 pp |
| 2024 | 92.1% | CN¥2.02 Billion | CN¥2.20 Billion | CN¥173.61 Million | ▼ -0.9 pp |
| 2023 | 93.0% | CN¥2.17 Billion | CN¥2.34 Billion | CN¥163.41 Million | ▲ +6.6 pp |
| 2022 | 86.4% | CN¥2.47 Billion | CN¥2.86 Billion | CN¥389.46 Million | ▼ -3.2 pp |
| 2021 | 89.6% | CN¥2.47 Billion | CN¥2.76 Billion | CN¥286.76 Million | ▼ 0.0 pp |
| 2020 | 89.6% | CN¥2.19 Billion | CN¥2.44 Billion | CN¥254.33 Million | ▲ +19.6 pp |
| 2019 | 70.0% | CN¥2.39 Billion | CN¥3.41 Billion | CN¥1.03 Billion | ▲ +4.3 pp |
| 2018 | 65.7% | CN¥2.82 Billion | CN¥4.29 Billion | CN¥1.47 Billion | ▼ -7.3 pp |
| 2017 | 73.0% | CN¥2.92 Billion | CN¥4.00 Billion | CN¥1.08 Billion | ▼ -21.0 pp |
| 2016 | 94.0% | CN¥2.53 Billion | CN¥2.69 Billion | CN¥160.16 Million | ▲ +5.3 pp |
| 2015 | 88.7% | CN¥2.14 Billion | CN¥2.42 Billion | CN¥271.92 Million | ▼ -8.6 pp |
| 2014 | 97.4% | CN¥749.40 Million | CN¥769.49 Million | CN¥20.08 Million | ▲ +2.0 pp |
| 2013 | 95.4% | CN¥738.31 Million | CN¥773.80 Million | CN¥35.49 Million | ▼ -1.2 pp |
| 2012 | 96.6% | CN¥704.41 Million | CN¥729.02 Million | CN¥24.62 Million | ▼ -0.8 pp |
| 2011 | 97.4% | CN¥672.28 Million | CN¥690.19 Million | CN¥17.91 Million | ▲ +12.8 pp |
| 2010 | 84.6% | CN¥177.34 Million | CN¥209.68 Million | CN¥32.34 Million | ▲ +5.9 pp |
| 2009 | 78.6% | CN¥129.71 Million | CN¥164.95 Million | CN¥35.24 Million | ▼ -2.3 pp |
| 2008 | 80.9% | CN¥116.12 Million | CN¥143.53 Million | CN¥27.41 Million | ▼ -7.0 pp |
| 2007 | 87.9% | CN¥83.94 Million | CN¥95.54 Million | CN¥11.60 Million | — |